Lam Research Corporation $LRCX Shares Acquired by GAMMA Investing LLC

GAMMA Investing LLC grew its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 12.1% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 30,449 shares of the semiconductor company’s stock after purchasing an additional 3,297 shares during the period. GAMMA Investing LLC’s holdings in Lam Research were worth $4,077,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the business. IMG Wealth Management Inc. purchased a new stake in Lam Research during the 2nd quarter worth $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research during the second quarter worth about $27,000. Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research in the second quarter worth about $29,000. Delos Wealth Advisors LLC acquired a new stake in shares of Lam Research in the second quarter valued at about $30,000. Finally, REAP Financial Group LLC purchased a new stake in shares of Lam Research during the 2nd quarter valued at about $31,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the sale, the senior vice president directly owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Ava Harter sold 9,010 shares of the stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the completion of the transaction, the insider owned 56,786 shares of the company’s stock, valued at $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 102,608 shares of company stock worth $14,916,496 over the last 90 days. Insiders own 0.31% of the company’s stock.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $164.30 on Tuesday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $206.37 billion, a price-to-earnings ratio of 36.19, a price-to-earnings-growth ratio of 1.65 and a beta of 1.77. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $169.69. The business has a 50 day simple moving average of $152.83 and a 200-day simple moving average of $121.06.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the previous year, the company posted $0.86 earnings per share. The firm’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities research analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.6%. Lam Research’s payout ratio is presently 22.91%.

Wall Street Analyst Weigh In

LRCX has been the topic of a number of recent research reports. Wells Fargo & Company boosted their target price on shares of Lam Research from $135.00 to $145.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 23rd. Rothschild & Co Redburn boosted their price objective on shares of Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Dbs Bank raised their target price on Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. Barclays set a $142.00 target price on Lam Research and gave the stock an “equal weight” rating in a research report on Monday, October 20th. Finally, BNP Paribas Exane increased their price target on Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a report on Thursday, October 23rd. Twenty-six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, Lam Research has a consensus rating of “Moderate Buy” and an average price target of $156.21.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.